Nicotine differentially modulates antisaccade performance in healthy male non-smoking volunteers stratified for low and high accuracy

Psychopharmacology

Volumn 221, Issue 1, 2012, Pages 27-38

  Petrovsky, Nadine ^a   Ettinger, Ulrich ^b   Quednow, Boris B ^c   Walter, Henrik ^d   Schnell, Knut ^e   Kessler, Henrik ^a   Mössner, Rainald ^a   Maier, Wolfgang ^a   Wagner, Michael ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL OF PSYCHIATRY   (Switzerland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Acetylcholine; Antisaccade; Attention; Executive function; Nicotine; Oculomotor control

Indexed keywords

NICOTINE PATCH; NIQUITIN CLEAR; PLACEBO; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXECUTIVE FUNCTION; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NAUSEA; NORMAL HUMAN; PATIENT COMPLIANCE; PRIORITY JOURNAL; RESPONSE TIME; SACCADIC EYE MOVEMENT; SYMPTOM; TASK PERFORMANCE; VISUAL ANALOG SCALE; VOMITING;

ADULT; COGNITION; DOUBLE-BLIND METHOD; HUMANS; INDIVIDUALITY; MALE; MIDDLE AGED; NICOTINE; PSYCHOMOTOR PERFORMANCE; REACTION TIME; SACCADES; YOUNG ADULT;

EID: 84859642317     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2540-9     Document Type: Article

References (50)

1. Allman AA, Benkelfat C, Durand F, Sibon I, Dagher A, Leyton M, Baker GB, O'Driscoll GA (2010) Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology (Berl) 211:423-433
2. Barr RS, Culhane MA, Jubelt LE, Mufti RS, Dyer MA, Weiss AP, Deckersbach T, Kelly JF, Freudenreich O, Goff DC, Evins AE (2008) The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 33:480-490
3. Bland JM, Altman DG (1994) Regression towards the mean. Bmj 308:1499 (Pubitemid 24170175)
4. Bowling AC, Donnelly JF (2010) Effect of nicotine on saccadic eye movement latencies in non-smokers. Hum Psychopharmacol 25:410-418
5. Braff DL, Geyer MA, Swerdlow NR (2001) Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl) 156:234-258 (Pubitemid 32705488)
6. Calkins ME, Iacono WG, Ones DS (2008) Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes. Brain Cogn 68:436-461
7. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum, Hillsdale
8. Csomor PA, Stadler RR, Feldon J, Yee BK, Geyer MA, Vollenweider FX (2008) Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels. Neuropsychopharmacology 33:497-512
9. Dafoe JM, Armstrong IT, Munoz DP (2007) The influence of stimulus direction and eccentricity on pro- and anti-saccades in humans. Exp Brain Res 179:563-570 (Pubitemid 46800597)
10. Dawkins L, Powell JH, West R, Powell J, Pickering A (2007) A double-blind placebo-controlled experimental study of nicotine: II - effects on response inhibition and executive functioning. Psychopharmacology (Berl) 190:457-467 (Pubitemid 46204463)
11. De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong AH (2006) Regulation of alpha7-nicotinic receptor subunit and alpha7-like gene expression in the prefrontal cortex of patients with bipolar disorder and schizophrenia. Acta Psychiatr Scand 114:211-215 (Pubitemid 44186251)
12. Dépatie L, O'Driscoll GA, Holahan AL, Atkinson V, Thavundayil JX, Kin NN, Lal S (2002) Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27:1056-1070 (Pubitemid 35447643)
13. Ettinger U, Kumari V, Crawford TJ, Davis RE, Sharma T, Corr PJ (2003) Reliability of smooth pursuit, fixation, and saccadic eye movements. Psychophysiology 40:620-628 (Pubitemid 36834961)
14. Ettinger U, Ffytche DH, Kumari V, Kathmann N, Reuter B, Zelaya F, Williams SC (2008) Decomposing the neural correlates of antisaccade eye movements using event-related fMRI. Cereb Cortex 18:1148-1159
15. Ettinger U, Williams SC, Patel D, Michel TM, Nwaigwe A, Caceres A, Mehta MA, Anilkumar AP, Kumari V (2009) Effects of acute nicotine on brain function in healthy smokers and non-smokers: estimation of inter-individual response heterogeneity. NeuroImage 45:549-561
16. Faul F, Erdfelder E, Lang AG, Buchner A (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175-191
17. Fischer B, Weber H (1997) Effects of stimulus conditions on the performance of antisaccades in man. Exp Brain Res 116:191-200 (Pubitemid 27406210)
18. Freedman R, Hall M, Adler LE, Leonard S (1995) Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 38:22-33
19. Freedman R, Olincy A, Buchanan RW, Harris JG, Gold JM, Johnson L, Allensworth D, Guzman-Bonilla A, Clement B, Ball MP, Kutnick J, Pender V, Martin LF, Stevens KE, Wagner BD, Zerbe GO, Soti F, Kem WR (2008) Initial phase 2 trial of a nicotinic agonist in schizophrenia. Am J Psychiatry 165:1040-1047
20. Friedman JI, Temporini H, Davis KL (1999) Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biol Psychiatry 45:1-16 (Pubitemid 29049199)
21. Heishman SJ, Henningfield JE (2000) Tolerance to repeated nicotine administration on performance, subjective, and physiological responses in nonsmokers. Psychopharmacology (Berl) 152:321-333
22. Heishman SJ, Taylor RC, Henningfield JE (1994) Nicotine and smoking: a review of effects on human perfomance. Exp Clin Psychopharmacol 2:345-395
23. Heishman SJ, Kleykamp BA, Singleton EG (2010) Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology (Berl) 210:453-469
24. Kimberg DY, D'Esposito M, Farah MJ (1997) Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8:3581-3585 (Pubitemid 27497487)
25. Kitagawa H, Takenouchi T, Azuma R, Wesnes KA, Kramer WG, Clody DE, Burnett AL (2003) Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28:542-551
26. Klein C, Ettinger U (2008) A hundred years of eye movement research in psychiatry. Brain Cogn 68:215-218
27. Klein C, Wendling K, Huettner P, Ruder H, Peper M (2006) Intra-subject variability in attention-deficit hyperactivity disorder. Biol Psychiatry 60:1088-1097 (Pubitemid 44754856)
28. Knott VJ, Fisher DJ, Millar AM (2010) Differential effects of nicotine on P50 amplitude, its gating, and their neural sources in low and high suppressors. Neuroscience 170:816-826
29. Larrison-Faucher AL, Matorin AA, Sereno AB (2004) Nicotine reduces antisaccade errors in task impaired schizophrenic subjects. Prog Neuropsychopharmacol Biol Psychiatry 28:505-516 (Pubitemid 38490763)
30. Lehrl S (1989) Mehrfachwahl-Wortschatz-Intelligenztest (MWT-B), 2nd ed. Erlangen, Germany
31. Levin ED, Conners CK, Silva D, Hinton SC, Meck WH, March J, Rose JE (1998) Transdermal nicotine effects on attention. Psychopharmacology (Berl) 140:135-141 (Pubitemid 28538472)
32. Mattay VS, Callicott JH, Bertolino A, Heaton I, Frank JA, Coppola R, Berman KF, Goldberg TE, Weinberger DR (2000) Effects of dextroamphetamine on cognitive performance and cortical activation. NeuroImage 12:268-275
33. Mehta MA (2002) Where do we go from here? The importance of initial values. Neuropsychopharmacology 27:879-880, author reply 881
34. Mehta MA, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000) Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20:RC65
35. Munoz DP, Everling S (2004) Look away: the anti-saccade task and the voluntary control of eye movement. Nat Rev Neurosci 5:218-228 (Pubitemid 38252478)
36. Nandam LS, Hester R, Wagner J, Cummins T, Garner K, Dean AJ, Kim BN, Nathan PJ, Mattingley JB, Bellgrove MA (2011) Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biol Psychiatry 69:902-904
37. Newhouse PA, Potter A, Singh A (2004) Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4:36-46 (Pubitemid 38145836)
38. Olincy A, Harris JG, Johnson LL, Pender V, Kongs S, Allensworth D, Ellis J, Zerbe GO, Leonard S, Stevens KE, Stevens JO, Martin L, Adler LE, Soti F, Kem WR, Freedman R (2006) Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia. Arch Gen Psychiatry 63:630-638 (Pubitemid 43848294)
39. Petrovsky N, Quednow BB, Ettinger U, Schmechtig A, Mössner R, Collier DA, Kühn KU, Maier W, Wagner M, Kumari V (2010) Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers. Neuropsychopharmacology 35:1429-1439
40. Poltavski DV, Petros T (2006) Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits. Physiol Behav 87:614-624 (Pubitemid 43356697)
41. Potter D, Summerfelt A, Gold J, Buchanan RW (2006) Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia. Schizophr Bull 32:692-700 (Pubitemid 44412856)
42. Ribeiz SR, Bassitt DP, Arrais JA, Avila R, Steffens DC, Bottino CM (2010) Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature. CNS Drugs 24:303-317
43. Robbins TW, Sahakian BJ (1979) "Paradoxical" effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology. Neuropharmacology 18:931-950 (Pubitemid 10117383)
44. Rycroft N, Hutton SB, Rusted JM (2006) The antisaccade task as an index of sustained goal activation in working memory: modulation by nicotine. Psychopharmacology (Berl) 188:521-529
45. Rycroft N, Hutton SB, Clowry O, Groomsbridge C, Sierakowski A, Rusted JM (2007) Non-cholinergic modulation of antisaccade performance: a modafinil-nicotine comparison. Psychopharmacology (Berl) 195:245-253
46. Severance EG, Yolken RH (2008) Novel alpha7 nicotinic receptor isoforms and deficient cholinergic transcription in schizophrenia. Genes Brain Behav 7:37-45
47. Vollenweider FX, Barro M, Csomor PA, Feldon J (2006) Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Biol Psychiatry 60:597-603 (Pubitemid 44402382)
48. Wilder J (1958) Modern psychophysiology and the law of initial value. Am J Psychother 12:199-221
49. Wittchen H-U, Wunderlich U, Gruschwitz S, Zaudig M (1997) SKIDI. Strukturiertes Klinisches Interview für DSM-IV. Achse I: Psychische Störungen. Interviewheft. (SCID-I. Structured Clinical Interview for DSM-IV, German version). Göttingen: Hogrefe
50. World Health Organization, International Society of Hypertension Writing Group (2003) World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 21:1983-1992